Becton, Dickinson and Co (XSWX:BDX) Total Current Assets : CHF9,188 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Becton, Dickinson and Co Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Becton, Dickinson and Co's total current assets for the quarter that ended in Mar. 2024 was CHF9,188 Mil.

Becton, Dickinson and Co Total Current Assets Historical Data

The historical data trend for Becton, Dickinson and Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co Total Current Assets Chart

Becton, Dickinson and Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Current Assets

Get a 7-Day Free Trial

6,601.36

8,205.74

8,155.71

7,923.64

7,804.93

Becton, Dickinson and Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															8,872.77	7,732.64	7,804.93	7,053.31	9,188.12

Becton, Dickinson and Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Becton, Dickinson and Co's Total Current Assets for the fiscal year that ended in Sep. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1281.03	+	2279.586	+	2944.391	+	1299.923
	=	7,805

Becton, Dickinson and Co's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	2821.305	+	2273.927	+	2869.289	+	1223.603
	=	9,188

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Becton, Dickinson and Co (XSWX:BDX) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Becton, Dickinson and Co's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2821.305	-	25333.097	+	0.75 * 2273.927	+	0.5 * 2869.289
=	-19,372

Becton, Dickinson and Co Total Current Assets Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Becton, Dickinson and Co (XSWX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (XSWX:BDX) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

BDX:USA BDX:Mexico 1BDX:Italy BOX:Germany B1DX34:Brazil

Address

1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880

Website

https://www.bd.com

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.